Search

everythinglearnresearchcommunity

for

Search:↓

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

Plum-blossom needling with conventional treatments improves hair regrowth in alopecia areata.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

Oral cyclosporine works better than betamethasone minipulse therapy for treating Alopecia Areata.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Dermoscopy is a useful tool for diagnosing and managing alopecia areata.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Alopecia areata patients have more Propionibacterium acnes and less Staphylococcus epidermidis on their scalps.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.